Compare
Chemed vs Labcorp (CHE vs LH)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Chemed (CHE) returned +20.3% and Labcorp (LH) +46.2%; so far this year the figures are +23.4% and +46.1%.
Labcorp is the larger company by market value, about 4.3 times the size of Chemed.
On trailing earnings, CHE trades at 25.3 times and LH at 30.1 times.
Revenue grew +15.6% at CHE and +6.0% at LH over the last year.
CHE yields 0.47%. LH yields 0.79%.
Data as of the latest close. Not investment advice.
Relative performance
| CHE | LH | |
|---|---|---|
| Price | $528.05 | $366.57 |
| 1-day | -1.07% | +0.90% |
| YTD | +23.42% | +46.11% |
| 1 year | +20.28% | +46.22% |
| 3 years | -8.32% | +79.74% |
| Market cap | $6.9B | $29.8B |
| P/E | 25.3 | 30.1 |
| P/S | 2.58 | 2.04 |
| P/B | 7.98 | 3.36 |
| Revenue growth | +15.60% | +6.00% |
| EPS growth | +10.40% | +19.60% |
| Gross margin % | 33.5 | 29.0 |
| Net margin % | 10.6 | 6.9 |
| ROE % | 32.8 | 11.3 |
| Debt / equity | 0.28 | 0.66 |
| FCF yield % | 4.3 | 4.3 |
| Dividend yield % | 0.47 | 0.79 |
| Beta | 0.10 | 0.38 |
| RSI (14) | 53.0 | 69.9 |
| Technical rating |